HeartBeam, Inc. (BEAT) Stock

HeartBeam, Inc. (BEAT) is a Healthcare stock trading at $0.65 (as of 2026-07-07), with a market capitalization of $28.12M. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.

HeartBeam, Inc. provides remote telehealth technology for detecting and monitoring cardiac disease outside traditional healthcare settings. Its system includes a portable single‑lead electrocardiogram device and cloud-based diagnostic software that generates information used by clinicians in managing patients with cardiovascular conditions.

Valuation — source: SEC EDGAR (first-party)
Price$0.65
Market Cap$28.12M
EV / EBITDA-1.0
Price / Book3.44
FCF Yield-49.8%
Profitability & Growth — source: SEC EDGAR
Return on Equity-248.2%
Current Ratio3.66
Valuation vs Sector & Industry
Sector P/E (Healthcare)21.6
Industry P/E (Medical Equipment)32.9
Smart-Money Activity — SEC Form 4 / 13F / Congressional disclosures
Top Institutional HolderBlackRock Fund Advisors ($51.69M)
Institutional Holders Tracked10
Company
SectorHealthcare
IndustryMedical Equipment
CEORobert Eno
Employees21
CountryUS
IPO Date2021-11-11

Related Companies (Business model: Medical Devices / Life Science Tools; 8 closest by market cap; US-domiciled)

  • Xtant Medical Holdings, Inc. (XTNT)
  • PAVmed Inc. (PAVM)
  • SANUWAVE Health, Inc. (SNWV)
  • Accuray Incorporated (ARAY)
  • Plus Therapeutics, Inc. (PSTV)
  • Modular Medical, Inc. (MODD)
  • Retractable Technologies, Inc. (RVP)
  • NeuroOne Medical Technologies Corporation (NMTC)
BEAT earnings history · BEAT institutional & insider holders · BEAT KPIs & operating metrics · BEAT financials · BEAT investor presentations & press releases · BEAT SEC filings · BEAT peers · Congress trades · Insider trades · Short interest · Stock screener

Data as of 2026-07-07.

Figures sourced from U.S. Securities and Exchange Commission (SEC EDGAR) filings and market data. Not personalized investment advice.